Spider cardiac physiology. II. Responses of a tarantula heart to cholinergic compounds.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005724:Ganglia / Q000187:drug effects; D006321:Heart / Q000187:drug effects*; D006339:Heart Rate / Q000187:drug effects; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D008688:Methacholine Compounds / Q000494:pharmacology; D009129:Muscle Tonus / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology; D010277:Parasympathomimetics / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects; D013112:Spiders / Q000502:physiology*; D013997:Time Factors; D014403:Tubocurarine / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D006584:Hexamethonium Compounds; D008688:Methacholine Compounds; D010277:Parasympathomimetics; D011950:Receptors, Cholinergic; D009538:Nicotine; D001285:Atropine; D010830:Physostigmine; D000109:Acetylcholine; D014403:Tubocurarine